Catalio Capital Management, LP Quant / Systematic

CIK: 0001958125 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $540,930 (100.0% shares, 0.0% debt)

Holdings (38)

LLY ELI LILLY & CO 8.1%
Value ($000) $43,778 Shares 57,376 Est. Cost $793.52 Unrealized -6.5%
ABBV ABBVIE INC 6.6%
Value ($000) $35,850 Shares 154,834 Est. Cost $201.95 Unrealized 0.0%
BBIO BRIDGEBIO PHARMA INC 6.0%
Value ($000) $32,345 Shares 622,729 Est. Cost $26.37 Unrealized +85.0%
ISRG INTUITIVE SURGICAL INC 5.9%
Value ($000) $31,907 Shares 71,343 Est. Cost $513.00 Unrealized -6.5%
ASND ASCENDIS PHARMA A/S 5.3%
Value ($000) $28,818 Shares 144,954 Est. Cost $137.67 Unrealized
SLNO SOLENO THERAPEUTICS INC 5.2%
Value ($000) $28,273 Shares 418,245 Est. Cost $64.77 Unrealized +14.5%
DNTH DIANTHUS THERAPEUTICS INC 4.9%
Value ($000) $26,271 Shares 667,615 Est. Cost $25.71 Unrealized -0.6%
BSX BOSTON SCIENTIFIC CORP 4.7%
Value ($000) $25,674 Shares 262,972 Est. Cost $101.49 Unrealized +2.0%
SNDX SYNDAX PHARMACEUTICALS INC 4.6%
Value ($000) $24,842 Shares 1,614,717 Est. Cost $13.56 Unrealized -3.5%
CYTK CYTOKINETICS INC 4.6%
Value ($000) $24,819 Shares 451,581 Est. Cost $50.21 Unrealized -18.0%
NTRA NATERA INC 4.4%
Value ($000) $23,883 Shares 148,369 Est. Cost $156.65 Unrealized +1.0%
REGN REGENERON PHARMACEUTICALS 3.7%
Value ($000) $19,873 Shares 35,344 Est. Cost $564.28 Unrealized 0.0%
GPCR STRUCTURE THERAPEUTICS INC 3.4%
Value ($000) $18,251 Shares 651,810 Est. Cost $25.23 Unrealized
QURE UNIQURE NV 3.1%
Value ($000) $16,515 Shares 282,940 Est. Cost $8.63 Unrealized +110.3%
IRON DISC MEDICINE INC 2.6%
Value ($000) $14,308 Shares 216,527 Est. Cost $57.71 Unrealized +3.1%
ABVX ABIVAX SA 2.5%
Value ($000) $13,766 Shares 162,141 Est. Cost $84.90 Unrealized
SUPN SUPERNUS PHARMACEUTICALS INC 2.5%
Value ($000) $13,720 Shares 287,090 Est. Cost $40.27 Unrealized 0.0%
EXAS EXACT SCIENCES CORP 2.5%
Value ($000) $13,622 Shares 248,987 Est. Cost $49.96 Unrealized 0.0%
PHAT PHATHOM PHARMACEUTICALS INC 2.5%
Value ($000) $13,283 Shares 1,128,521 Est. Cost $7.47 Unrealized +38.2%
ADPT ADAPTIVE BIOTECHNOLOGIES COR 2.4%
Value ($000) $13,238 Shares 884,890 Est. Cost $8.47 Unrealized +43.8%
RNAM AVIDITY BIOSCIENCES INC 2.1%
Value ($000) $11,470 Shares 263,256 Est. Cost $40.43 Unrealized 0.0%
ADMA ADMA BIOLOGICS INC 1.9%
Value ($000) $10,035 Shares 684,508 Est. Cost $19.85 Unrealized -13.6%
RARE ULTRAGENYX PHARMACEUTICAL IN 1.6%
Value ($000) $8,761 Shares 291,262 Est. Cost $34.43 Unrealized -12.9%
GUTS FRACTYL HEALTH INC 1.5%
Value ($000) $8,291 Shares 5,214,236 Est. Cost $1.34 Unrealized -3.2%
GRAL GRAIL INC 1.5%
Value ($000) $8,156 Shares 137,928 Est. Cost $38.21 Unrealized 0.0%
TARA PROTARA THERAPEUTICS INC 1.2%
Value ($000) $6,528 Shares 1,500,793 Est. Cost $3.30 Unrealized -2.0%
SEPN SEPTERNA INC 1.0%
Value ($000) $5,537 Shares 294,360 Est. Cost $23.65 Unrealized -44.5%
CIDARA THERAPEUTICS INC 0.9%
Value ($000) $5,107 Shares 53,333 Est. Cost $95.76 Unrealized
KYTX KYVERNA THERAPEUTICS INC 0.7%
Value ($000) $3,521 Shares 586,909 Est. Cost $4.79 Unrealized -16.6%
ELDN ELEDON PHARMACEUTICALS INC 0.5%
Value ($000) $2,748 Shares 1,061,132 Est. Cost $2.92 Unrealized 0.0%
OM OUTSET MED INC 0.3%
Value ($000) $1,670 Shares 118,279 Est. Cost $11.92 Unrealized +30.8%
MGX METAGENOMI INC 0.2%
Value ($000) $1,254 Shares 528,993 Est. Cost $2.41 Unrealized -15.9%
ATAI LIFE SCIENCES NV 0.2%
Value ($000) $1,041 Shares 196,858 Est. Cost $1.33 Unrealized
HYPR HYPERFINE INC 0.2%
Value ($000) $993 Shares 684,541 Est. Cost $0.96 Unrealized +21.4%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 0.2%
Value ($000) $955 Shares 133,131 Est. Cost $42.39 Unrealized +22.9%
KPTI KARYOPHARM THERAPEUTICS INC 0.2%
Value ($000) $935 Shares 142,984 Est. Cost $8.54 Unrealized -37.0%
PVLA PALVELLA THERAPEUTICS INC NE 0.1%
Value ($000) $753 Shares 12,010 Est. Cost $44.59 Unrealized 0.0%
SNSE SENSEI BIOTHERAPEUTICS INC 0.0%
Value ($000) $139 Shares 14,718 Est. Cost $7.18 Unrealized +15.6%